Related Experiment Video
Updated: Jul 16, 2026
07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Deferoxamine Exhibits Antimicrobial and Immunomodulatory Activity Against Mycobacterium abscessus: Integrated In
Roseane Lustosa de Santana Lira1, Fabiane Barbosa Mendes2, Pedro Lucas Brito Tromps Roxo3
1Postgraduate Program in Health Sciences, Federal University of Maranhão-UFMA, São Luís 65080-805, Brazil.
International Journal of Molecular Sciences
|July 15, 2026
Summary
Deferoxamine (DFO), an iron chelator, shows promise as an adjuvant therapy against Mycobacterium abscessus subsp. massiliense infections. DFO demonstrated synergistic effects with clarithromycin and reduced bacterial virulence factors.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Mycobacterium abscessus subsp. massiliense (Mabs) causes difficult-to-treat infections due to drug resistance and persistence.
- Adjuvant therapies targeting iron metabolism may enhance conventional antimicrobial efficacy against Mabs.
Purpose of the Study:
- To investigate deferoxamine (DFO), an iron chelator, as a potential adjuvant against Mabs.
- To evaluate DFO's effects on Mabs virulence and host immune response.
Main Methods:
- In vitro assays (cytotoxicity, antimicrobial activity, checkerboard synergy, biofilm formation).
- In silico analyses (molecular docking, ADME/Tox, PASS).
- Infected macrophage models (intracellular activity, gene expression analysis).
Main Results:
- DFO showed low cytotoxicity and negligible hemolytic activity.
- DFO exhibited a bacteriostatic profile but synergistic interaction with clarithromycin.
- DFO reduced Mabs biofilm formation, intracellular burden, and modulated cytokine expression.
Conclusions:
- DFO is a promising experimental adjuvant for Mabs infections, especially combined with clarithromycin.
- Further studies are needed to confirm its iron-restriction mechanism and clinical relevance.
Related Concept Videos
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...